Return to Issue Details RESULTS OF NEOADJUVANT CHEMOTHERAPY TREATMENT FOR HER2(+) BREAST CANCER USING A COMBINATION CHEMOTHERAPY REGIMEN WITH HER2 INHIBITORS AT NGHE AN ONCOLOGY HOSPITAL. Download Download PDF